Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
2018 · Clinical Lymphoma Myeloma & Leukemia · 89 citations
https://doi.org/10.1016/j.clml.2018.06.018
R
Rose‐Marie Hamladji
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
595
Citations
11
h-index
17
i10-index
Rose‐Marie Hamladji is an academic researcher from University of Algiers Benyoucef Benkhedda. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Lymphoblastic Leukemia research & Acute Myeloid Leukemia Research. The author has an h-index of 11, co-authored 54 publications.
Papers by this author
worksHematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO)
2013 · Hematology/Oncology and Stem Cell Therapy · 25 citations
https://doi.org/10.1016/j.hemonc.2013.04.001
Efficacy and Outcome of Allogeneic Transplantation in IgD and Nonsecretory Myeloma. A Report on Behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
2015 · Biology of Blood and Marrow Transplantation · 5 citations
https://doi.org/10.1016/j.bbmt.2015.02.012
Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP
2024 · Bone Marrow Transplantation · 5 citations
https://doi.org/10.1038/s41409-024-02286-3
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
2021 · Bone Marrow Transplantation · 1 citations
https://doi.org/10.1038/s41409-021-01424-5
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party
2017 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 0 citations
https://doi.org/10.60692/109j1-xr964
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat